Business · 11/09/2026
FDA Classifies Cardiovascular Machine Learning-Based Notification Software as Class II Device
The FDA has classified the cardiovascular machine learning-based notification software as a Class II device, which will provide a reasonable assurance of its safety and effectiveness, and reduce regulatory burdens, ultimately enhancing patients' access to innovative devices.
Original source language: Federal Register — Health and Human ServicesOpen original release →